Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1985-01-08
1992-05-26
Doll, John
Drug, bio-affecting and body treating compositions
Lymphokine
435 7021, 4351722, 43524027, 435188, 435212, 435215, 435216, 53038825, 5303917, 5303879, A61K 39395, C07K 1528
Patent
active
051166135
ABSTRACT:
A thrombolytic product comprising a fibrin-specific antibody substantially devoid of fibrinogen cross-reactivity coupled to a thrombolytic agent.
REFERENCES:
patent: 4147765 (1979-04-01), Stephan et al.
patent: 4245040 (1981-01-01), Pilgeram
Pacella, B. L. et al., Molecular Immunol., vol. 20(5):521-528 (1983) cited in Bio. Abstract 7606,9866.
Gaffney, P. J. et al., Haemostasis 10(6):304-311 (1981) cited in Bio. Abstract 74012197.
DeProst, D. et al., Thromb. Haemostasis. 50(4):792-796 (1983) cited in Bio. Abstract 78005612.
Hui et al., Thrombosis and Haemostasis, 54(2):524-527 (1985).
Carrasquillo et al., Radioimmunodetection of Human Melanoma with Monoclonal Antibodies, in Radioimaging and Radioimmunotherapy, Burchiol et al., eds, Elsevier Science, 1983.
Haber Edgar
Matsueda Gary R.
Budens Robert D.
Doll John
The General Hospital Corporation
LandOfFree
Antibody-thrombolytic agent product and method of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibody-thrombolytic agent product and method of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody-thrombolytic agent product and method of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-418187